4//SEC Filing
Burakoff Steven 4
Accession 0001225208-11-011383
CIK 0000732485other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 12:56 PM ET
Size
10.1 KB
Accession
0001225208-11-011383
Insider Transaction Report
Form 4
GENZYME CORPGENZ
Burakoff Steven
Director
Transactions
- Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+2,375→ 2,375 total - Disposition to Issuer
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−2,375$175,750→ 0 total - Exercise/Conversion
Restricted Stock Units
2011-04-04−2,375→ 0 totalExercise: $0.00→ Genzyme common stock (GENZ) (2,375 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$51.52/sh−7,125$367,080→ 0 totalExercise: $51.52Exp: 2020-06-16→ Genzyme common stock (GENZ) (7,125 underlying)
Footnotes (2)
- [F1]The vested restricted stock units were scheduled to vest on the date of the 2011 annual meeting of shareholders.
- [F2]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.
Documents
Issuer
GENZYME CORP
CIK 0000732485
Entity typeother
Related Parties
1- filerCIK 0001494276
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 12:56 PM ET
- Size
- 10.1 KB